A549
|
IC50 |
0.12 μM
Compound: 6; BBI608
|
Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by WST8 assay
Cytotoxicity against human A549 cells assessed as reduction in cell proliferation measured after 72 hrs by WST8 assay
|
[PMID: 32044231]
|
A549
|
IC50 |
0.74 μM
Compound: Nap; BBI608
|
Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 28558333]
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 48 hrs MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 48 hrs MTT assay
|
[PMID: 32631508]
|
AGS
|
IC50 |
|
Antiproliferative activity against human AGS cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Antiproliferative activity against human AGS cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36103247]
|
BXPC-3
|
IC50 |
|
Antiproliferative activity against human BxPC-3 cells harboring ZFP91siRNA assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against human BxPC-3 cells harboring ZFP91siRNA assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33506674]
|
BXPC-3
|
IC50 |
|
Antiproliferative activity against human BxPC-3 cells assessed as reduction in cell viability incubated for 3 days by MTT assay
Antiproliferative activity against human BxPC-3 cells assessed as reduction in cell viability incubated for 3 days by MTT assay
|
[PMID: 33506674]
|
BXPC-3
|
IC50 |
|
Antiproliferative activity against ZFP91 knockdown human BxPC-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
Antiproliferative activity against ZFP91 knockdown human BxPC-3 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
|
[PMID: 33506674]
|
BXPC-3
|
IC50 |
1962 nM
Compound: 1c; BBI608
|
Inhibition of ATP production in human BXPC-3 cells incubated for 20 to 24 hrs by ATP assay kit method
Inhibition of ATP production in human BXPC-3 cells incubated for 20 to 24 hrs by ATP assay kit method
|
[PMID: 36282975]
|
BXPC-3
|
IC50 |
5306 nM
Compound: 1c; BBI608
|
Anti-proliferative activity against human BXPC-3 cells assessed as cell growth inhibition incubated for 72 hrs by MTS assay
Anti-proliferative activity against human BXPC-3 cells assessed as cell growth inhibition incubated for 72 hrs by MTS assay
|
[PMID: 36282975]
|
Capan-2
|
IC50 |
1586 nM
Compound: 1c; BBI608
|
Anti-proliferative activity against human Capan-2 cells assessed as cell growth inhibition incubated for 72 hrs by MTS assay
Anti-proliferative activity against human Capan-2 cells assessed as cell growth inhibition incubated for 72 hrs by MTS assay
|
[PMID: 36282975]
|
CT26
|
IC50 |
2.5 μM
Compound: Napabucasin
|
Antiproliferative activity against mouse CT26 cells after 72 hrs by MTT assay
Antiproliferative activity against mouse CT26 cells after 72 hrs by MTT assay
|
[PMID: 30472602]
|
DU-145
|
IC50 |
|
Anticancer activity against human DU145 cells after 72 hrs by XTT assay
Anticancer activity against human DU145 cells after 72 hrs by XTT assay
|
[PMID: 18829316]
|
HaCaT
|
IC50 |
|
Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy
Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy
|
[PMID: 22845014]
|
HCT-116
|
IC50 |
0.3 μM
Compound: 87; BBI608
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation incubated for 72 hrs by CellTiter-Glo assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation incubated for 72 hrs by CellTiter-Glo assay
|
[PMID: 33445154]
|
HEK293
|
IC50 |
|
Antiproliferative activity against human HEK293 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Antiproliferative activity against human HEK293 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
|
[PMID: 33506674]
|
HepG2
|
IC50 |
0.66 μM
Compound: Nap; BBI608
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 28558333]
|
HepG2
|
IC50 |
|
Antiproliferative activity against human HepG2 cells overexpressed STAT3 assessed as reduction in cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human HepG2 cells overexpressed STAT3 assessed as reduction in cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 32603980]
|
HepG2
|
IC50 |
10.2 μM
Compound: BBI 608
|
Antiproliferative activity against human HepG2 cells after 48 hrs by CCK-8 assay
Antiproliferative activity against human HepG2 cells after 48 hrs by CCK-8 assay
|
[PMID: 29604543]
|
HepG2
|
IC50 |
6.6 μM
Compound: Napabucasin
|
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay
|
[PMID: 30472602]
|
HT-29
|
IC50 |
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability measured after 48 hrs MTT assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability measured after 48 hrs MTT assay
|
[PMID: 32631508]
|
HT-29
|
IC50 |
1.6 μM
Compound: Napabucasin
|
Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay
|
[PMID: 30472602]
|
HUVEC
|
IC50 |
41.28 μM
Compound: BBI608
|
Antiproliferative activity against human HUVEC cells assessed as inhibition of cell growth in measured after 72 hrs by MTT assay
Antiproliferative activity against human HUVEC cells assessed as inhibition of cell growth in measured after 72 hrs by MTT assay
|
[PMID: 34435487]
|
K562
|
IC50 |
|
Antiproliferative activity against human K562 cells measured after 48 hrs by MTT assay
Antiproliferative activity against human K562 cells measured after 48 hrs by MTT assay
|
[PMID: 30003778]
|
L02
|
IC50 |
18.7 μM
Compound: BBI 608
|
Antiproliferative activity against human L02 cells after 48 hrs by CCK-8 assay
Antiproliferative activity against human L02 cells after 48 hrs by CCK-8 assay
|
[PMID: 29604543]
|
MCF-10A
|
IC50 |
|
Cytotoxicity against human MCF10A cells assessed as reduction in cell viability measured after 48 hrs MTT assay
Cytotoxicity against human MCF10A cells assessed as reduction in cell viability measured after 48 hrs MTT assay
|
[PMID: 32631508]
|
MCF7
|
IC50 |
< 1 μM
Compound: 6; BBI608
|
Inhibition of IL-6 induced STAT3 phosphorylation at Tyr705 residue in human MCF7 cells preincubated for 1 hr followed by IL-6 stimulation and measured after 1 hr by Western blot analysis
Inhibition of IL-6 induced STAT3 phosphorylation at Tyr705 residue in human MCF7 cells preincubated for 1 hr followed by IL-6 stimulation and measured after 1 hr by Western blot analysis
|
[PMID: 32044231]
|
MCF7
|
IC50 |
0.24 μM
Compound: 6; BBI608
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell proliferation measured after 72 hrs by WST8 assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell proliferation measured after 72 hrs by WST8 assay
|
[PMID: 32044231]
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs MTT assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 48 hrs MTT assay
|
[PMID: 32631508]
|
MCF7
|
EC50 |
1.49 μM
Compound: BBI-608
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CyQuant assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CyQuant assay
|
[PMID: 33352047]
|
MCF7
|
IC50 |
11.42 μM
Compound: BBI608
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 34435487]
|
MDA-MB-231
|
IC50 |
0.25 μM
Compound: 6; BBI608
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell proliferation measured after 72 hrs by WST8 assay
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell proliferation measured after 72 hrs by WST8 assay
|
[PMID: 32044231]
|
MDA-MB-231
|
IC50 |
0.34 μM
Compound: Nap; BBI608
|
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by MTT assay
Cytotoxicity against human MDA-MB-231 cells assessed as growth inhibition after 72 hrs by MTT assay
|
[PMID: 28558333]
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells overexpressing STAT3 assessed as reduction in cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human MDA-MB-231 cells overexpressing STAT3 assessed as reduction in cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 32603980]
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability measured after 48 hrs MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability measured after 48 hrs MTT assay
|
[PMID: 32631508]
|
MDA-MB-231
|
EC50 |
|
Antiproliferative activity against human MDA-MB-231 cells harbouring STAT3 assessed as reduction in cell viability at upto 10 uM incubated for 72 hrs by CyQuant assay
Antiproliferative activity against human MDA-MB-231 cells harbouring STAT3 assessed as reduction in cell viability at upto 10 uM incubated for 72 hrs by CyQuant assay
|
[PMID: 33352047]
|
MDA-MB-231
|
IC50 |
10.97 μM
Compound: BBI608
|
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell growth measured after 72 hrs by MTT assay
|
[PMID: 34435487]
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
|
[PMID: 30003778]
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human drug tolerant MDA-MB-231/lapatinib cells assessed as inhibition of cell growth in measured after 72 hrs by MTT assay
Antiproliferative activity against human drug tolerant MDA-MB-231/lapatinib cells assessed as inhibition of cell growth in measured after 72 hrs by MTT assay
|
[PMID: 34435487]
|
MDA-MB-468
|
IC50 |
1.14 μM
Compound: 1; BBI608
|
Antiproliferative activity against human MDA-MB-468 cells assessed as reduction in cell growth measured after 48 hrs by CCK8 assay
Antiproliferative activity against human MDA-MB-468 cells assessed as reduction in cell growth measured after 48 hrs by CCK8 assay
|
[PMID: 33126089]
|
MDA-MB-468
|
IC50 |
|
Antiproliferative activity against human MDA-MB-468 cells overexpressing STAT3 assessed as reduction in cell growth incubated for 48 hrs by CCK-8 assay
Antiproliferative activity against human MDA-MB-468 cells overexpressing STAT3 assessed as reduction in cell growth incubated for 48 hrs by CCK-8 assay
|
[PMID: 32603980]
|
MGC-803
|
IC50 |
871.8 nM
Compound: BBI608
|
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36103247]
|
MIA PaCa-2
|
IC50 |
|
Antiproliferative activity against human MIA PaCa-2 cells assessed as reduction in cell viability incubated for 3 days by MTT assay
Antiproliferative activity against human MIA PaCa-2 cells assessed as reduction in cell viability incubated for 3 days by MTT assay
|
[PMID: 33506674]
|
MKN-45
|
IC50 |
|
Antiproliferative activity against human MKN-45 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
Antiproliferative activity against human MKN-45 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay
|
[PMID: 36103247]
|
PC-3
|
IC50 |
5.25 μM
Compound: Napabucasin
|
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
|
[PMID: 30472602]
|
U-251
|
IC50 |
2.6 μM
Compound: Napabucasin
|
Antiproliferative activity against human U251 cells after 72 hrs by MTT assay
Antiproliferative activity against human U251 cells after 72 hrs by MTT assay
|
[PMID: 30472602]
|